Full 2L QBank
Anaesthesia Inhalational Anesthetic Agents fa6abb5f

True about malignant hypehermia -

A
It is genetic, hypometabolic muscle disease
B
It is genetic, hypermetabolic muscle disease
C
It is preoperative complication
D
It is inherited in Autosomal recessive form
High-Yield Explanation
Malignant hypehermia (MH) is a rare genetic hyper metabolic muscle disease. The characteristic phenotypical signs & symptoms most commonly occur with exposure to inhaled anesthetic agents and Succinylcholine. Clinical Manifestations of Malignant Hypehermia: Early Signs: Elevated end-tidal carbon dioxide Tachypnea and/or tachycardia Masseter spasm, if succinylcholine has been used Generalized muscle rigidity Mixed metabolic and respiratory acidosis Profuse sweating Mottling of skin Cardiac arrhythmias Unstable blood pressure Late Signs Hyperkalemia Rapid increase of core body temperature- body temperature rises by 10C every 5 minutes Elevated creatine phosphokinase levels Gross myoglobinemia and myoglobinuria Cardiac arrest Disseminated intravascular coagulation

Related Anaesthesia MCQs

Practice 2,00,000+ NEET PG Questions Free

Timed mock tests, mistake queue analytics, audio lectures & zero attempt limits on i❤️Exams.

Start Free Mock Test Now